Description

Pyrrolo[3,2-C]Azepin-4(1H)-One, 5-[3-[4-(4-Fluorophenyl)-1-Piperazinyl]Propyl]-5,6,7,8-Tetrahydro-8-Hydroxy-1-Methyl- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting the central nervous system. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the production of innovative active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel psychoactive compounds and potential CNS (Central Nervous System) drug candidates.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic targets.
• Reference Standard: Serves as a certified reference material (CRM) for analytical method development and quality control in API manufacturing.
• Biochemical Research: Investigated for its interaction with specific biological receptors and enzymes in pharmacological studies.
• Process Chemistry Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale for new drug entities.

Basic Information

Item	Details
Product Name	Pyrrolo[3,2-C]Azepin-4(1H)-One, 5-[3-[4-(4-Fluorophenyl)-1-Piperazinyl]Propyl]-5,6,7,8-Tetrahydro-8-Hydroxy-1-Methyl-
CAS No.	191592-09-3
Molecular Formula	C23H30FN3O2
Molecular Weight	399.51 g/mol
Synonyms	5-[3-[4-(4-Fluorophenyl)-1-piperazinyl]propyl]-5,6,7,8-tetrahydro-8-hydroxy-1-methyl-1H-pyrrolo[3,2-c]azepin-4-one; 1-Methyl-5-[3-[4-(4-fluorophenyl)piperazin-1-yl]propyl]-5,6,7,8-tetrahydro-8-hydroxypyrrolo[3,2-c]azepin-4(1H)-one; 191592-09-3; UNII-9K9H0I3A1F; 9K9H0I3A1F; CHEMBL3183457; SCHEMBL15506299; BDBM50388875
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency and high purity. Quality is verified through a comprehensive suite of analytical techniques including HPLC, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting identity, purity, and impurity profiles. We support compliance with cGMP standards for pharmaceutical applications, and specifications can be tailored to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccant or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity	≤ 0.5%
Total Impurities	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.